NCT07021898
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07021898
Title A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. (BOREALIS-1)
Acronym BOREALIS-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Erasca, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.